Tuberculosis: 10. Prevention

Menzies, Dick; Nan Tannenbaum, Terry; FitzGerald, J. Mark
September 1999
CMAJ: Canadian Medical Association Journal;9/21/99, Vol. 161 Issue 6, p717
Academic Journal
Discusses ways to prevent the transmission of tuberculosis from patients with active, contagious forms of the disease to uninfected people in Canada. Details on prevention through prompt isolation of infected people and vaccination before exposure; Importance of identifying risk factors; Diagnosis of tuberculosis through testing; Treatment of the disease.


Related Articles

  • Infectious Diseases and Vaccine Sciences: Strategic Directions. Luby, Stephen P.; Brooks, W. Abdullah; Zaman, K.; Hossain, Shahed; Ahmed, Tahmeed // Journal of Health, Population & Nutrition;Sep2008, Vol. 26 Issue 3, p295 

    Despite substantial progress, infectious diseases remain important causes of ill-health and premature deaths in Bangladesh. Bangladesh has experienced a >90% reduction in the incidence of deaths due to childhood diarrhoea over the last 25 years. Further reductions can be achieved through the...

  • TUBERCULOSIS CONTROL: CHALLENGES OF AN ANCIENT AND ONGOING EPIDEMIC. Cummings, Kristin J. // Public Health Reports;Sep/Oct2007, Vol. 122 Issue 5, p683 

    The article focuses on the prevention of tuberculosis (TB). It discusses the benefits of the directly observed therapy (DOT) to patients. It states that several approaches have been employed in developing a better TB vaccine. It claims that the use of MVA85A vaccine as a booster for Bacille...

  • Mycobacterium tuberculosis Defective in Phthiocerol Dimycocerosate Translocation Provides Greater Protective Immunity against Tuberculosis than the Existing Bacille Calmette-Guérin Vaccine. Pinto, Rachel; Saunders, Bernadette M.; Camacho, Luis R.; Britton, Warwick J.; Gicquel, Brigitte; Triccas, James A. // Journal of Infectious Diseases;1/1/2004, Vol. 189 Issue 1, p105 

    Reports that Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides protective immunity against tuberculosis than the existing bacille Calmette-Guerin vaccine (BCG). Decreased capacity of Mycobacterium tuberculosis to replicate in mice; Factors that were not...

  • Tuberculosis: Is the Past Once Again Prologue? Comstock, George W. // American Journal of Public Health;Nov94, Vol. 84 Issue 11, p1729 

    Tuberculosis has been considered the result of hereditary susceptibility, miasmas in the environment and contact with contagious patients. During most of the latter half of this century, tuberculosis control efforts have concentrated almost exclusively on contagion by treating patients to make...

  • Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming. Gonçalves, Eduardo D. C.; Bonato, Vânia Luiza D.; da Fonseca, Denise M.; Soares, Edson G.; Brandão, Izaíra T.; Soares, Ana Paula M.; Silva, Célio L. // Genetic Vaccines & Therapy;2007, Vol. 5, p7 

    Vaccines are considered by many to be one of the most successful medical interventions against infectious diseases. But many significant obstacles remain, such as optimizing DNA vaccines for use in humans or large animals. The amount of doses, route and easiness of administration are also...

  • Dream, mirage, or Nemesis?  // British Medical Journal;12/25/1976, Vol. 2 Issue 6051, p1521 

    Examines the factors responsible for the fall in mortality from infectious diseases in Great Britain in the 19th and early 20th centuries. Changes in human nutrition; Decline in the mortality rate from tuberculosis due to the vaccine campaign; Offer of laboratory medicine in eliminating many...

  • Vaccines for TB: Lessons from the Past Translating into Future Potentials. Tye, Gee Jun; Lew, Min Han; Choong, Yee Siew; Lim, Theam Soon; Sarmiento, Maria Elena; Acosta, Armando; Norazmi, Mohd Nor // Journal of Immunology Research;6/3/2015, Vol. 2015, p1 

    Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of...

  • Disseminated BCG Infection (BCGosis) After BCG Vaccination. Poudel, P.; Chitlangia, M. // Journal of Nepal Paediatric Society;Jan-Apr2013, Vol. 34 Issue 1, p62 

    BCG vaccine has excellent safety profile. Disseminated BCG infection, so called BCGosis and death have occurred in few cases, mainly in those with impaired immunity. We are reporting a seven month old infant who developed BCGosis after BCG vaccination. She presented with weight loss, fever,...

  • Active surveillance for tuberculosis in Wales: 1996-2003. Fathoala, B.; Evans, M. R.; Campbell, I. A.; Sastry, J.; Alfaham, M. // Archives of Disease in Childhood;Nov2006, Vol. 91 Issue 11, p900 

    Aims: To estimate the incidence of active tuberculosis (TB) and study the use of chemoprophylaxis for latent TB in children in Wales, and to identify potential areas for improving prevention and management. Methods: Active surveillance for TB in children aged 0-15 years from July 1996 to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics